Steven Mc Carroll
About Steven Mc Carroll
Steven Mc Carroll serves as the Director of Genomic Neurobiology at the Broad Institute of MIT and Harvard and is a professor at Harvard Medical School. His research centers on the molecular and cellular processes that affect disease susceptibility, particularly in neurological and hematological disorders.
Work at Broad Institute
Steven Mc Carroll has been an Institute Member at the Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard since 2011. He serves as the Director of Genomic Neurobiology, a position he has held since 2017. In this role, he leads a laboratory that investigates the impact of genomic variation on neurological and hematological diseases. His research focuses on understanding how genetic variation influences biological function and susceptibility to diseases.
Current Role at Harvard Medical School
Since 2017, Steven Mc Carroll has held the title of Dorothy and Milton Flier Professor of Biomedical Science and Genetics at Harvard Medical School. His work at the institution builds on his previous experience as an Associate Professor of Genetics from 2009 to 2017. In his current role, he continues to explore the molecular and cellular processes that contribute to disease susceptibility, particularly in the context of neurological disorders.
Educational Background
Steven Mc Carroll completed his Ph.D. in Neuroscience at the University of California, San Francisco, from 1997 to 2004. Prior to that, he earned a Bachelor of Arts in Economics from Stanford University, studying from 1989 to 1993. His foundational education included attendance at Los Altos High School from 1985 to 1989, which set the stage for his academic pursuits in the sciences and economics.
Previous Experience
Before his academic career, Steven Mc Carroll worked as a research assistant at The Brookings Institution from 1994 to 1996. This role provided him with early exposure to research methodologies and contributed to his development as a scientist. His subsequent positions at Harvard Medical School and the Broad Institute have built upon this foundational experience, allowing him to focus on genomic research.